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Abstract
Background: Hygiene and skin care are effective and important interventions in the management
of lymphoedema secondary to lymphatic filariasis. We analyzed the impact on the quality of life that
education and introduction of a designated nurse had on lymphoedema patients in a community
that was endemic for lymphatic filariasis.
Methods: Patients' life quality was assessed using a Dermatology Life Quality Index (DLQI)
questionnaire. At the same time they received education on appropriate hygiene, skin care
techniques and simple exercises that encourage lymph drainage. A designated nurse was provided
with educational materials and treatments. The DLQI life quality measure was repeated one year
later.
Results: The DLQI improved for all patients and reported acute attacks were reduced. A paired
t-test showed the improvement in DLQI to be highly significant (P = < 0.0001).
Conclusions: A nurse-led service combined with patient education in communities endemic for
lymphatic filariasis is an effective intervention in improving the quality of life of patients with
lymphoedema.
Background
Lymphatic Filariasis (LF) leads to permanent lymphatic
dysfunction in virtually all infected individuals and clini-
cal disease in a subset of these [1]. A major sequalae of in-
fection is lymphoedema of the limbs – whereby
lymphatic dysfunction can lead to swelling of the limbs
which becomes permanent and, with repeated painful ep-
isodes of bacterial lymphangitis, known as 'acute attacks',
causes considerable acute morbidity and progression of
lymphoedema to elephantiasis [2].
In common with other skin diseases, lymphoedema has a
negative impact on patient quality of life. However most
studies on the impact on quality of life have been in the
developed world on post-mastectomy patients [3,4]. Lym-
phoedema secondary to lymphatic filariasis has not been
clearly assessed or compared with other skin conditions.
The Dermatology Life Quality Index (DLQI) is a question-
naire that has been shown to be an accurate way of assess-
ing the effect skin disease has on quality of life [5]. The
DLQI contains ten questions which assess how skin dis-
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ease has been affecting the individual's quality of life over
the past week and covers symptoms, feelings, daily activi-
ties, leisure, work, personal relationships and treatment.
Each question can score 0–3 points with the total range
being 0–30 [See additional file 1].
As a measure of life quality the DLQI has been validated
in the United Kingdom and applied to many skin condi-
tions world wide including in developing countries [6,7].
Furthermore, the DLQI has recently been validated as a
tool to monitor changes in quality of life [8]. There has
not yet been any published work on its use with lym-
phoedema patients. This study introduces the use of the
DLQI for patients with limb lymphoedema. It was used in
this setting, rather than a general health inventory to
measure quality of life, as this study was looking in partic-
ular at the impact of the introduction of a hygiene and
skin care regimen to patients.
Work has shown that the model, established in Brazil by
Gerusa Dreyer, of hygiene and skin care is the most effec-
tive treatment for lymphoedema secondary to LF [9–11].
Unpublished work in Haiti has already shown a positive
impact on disease and certain measures of life quality by
implementing this model [Dahl B, personal communica-
tion]. Further work is needed to see if these interventions
can work in other LF endemic regions.
Guyana is a low-income country on the Caribbean coast
of South America with a population of 750,000, concen-
trated in the coastal region. The Guyanese Ministry of
Health, with support from Pan American Health Organi-
zation (PAHO), recently established a national pro-
gramme to address LF and its public health implications.
Mapping exercises completed last year show that the prev-
alence of lymphatic filariasis in Guyanese school children
[as determined by the presence of Circulating Filarial An-
tigen (CFA)] is as high as 45% in some areas. In Wismar,
the study area, CFA prevalence was found to be 33%.
There was no information on morbidity, or any formal
programme to provide disease sufferers with support until
2001 when PAHO and the World Health Organization
(WHO) began working with the Ministry of Health on
this issue.
Initial work on morbidity was carried out in Guyana be-
tween April and June 2001, at the same time as this study
was being initiated. This involved use of clinic data and
interviews with health workers and patients including a
testing of the applicability of the use DLQI in a sample of
patients in the vector control clinic in Georgetown. These
investigations revealed a significant burden of disease and
a poor level of knowledge of the mechanisms of the dis-
ease and effective treatments. There was haphazard and
inconsistent care, with poor facilities for lymphoedema
patients, and a feeling of impotence among health care
workers and patients. The initial interviews for this study
were carried out at the inception of Guyana's national LF
programme and before the introduction of any morbidity
programmes either nationally or locally.
This short paper reports on the effect on the quality of life
of lymphoedema patients following introduction of a hy-
giene and skin care regimen in one community endemic
for lymphatic filariasis in Guyana.
Methods
Wismar is a municipality within the bauxite-mining town
of Linden, located 107 kilometres from Georgetown.
Linden's population is 30,000. Discussions with a local
doctor during the first visit to implement mapping studies
revealed patients with lymphoedema within the commu-
nity who were currently receiving no organized care. The
doctor identified a group of 15 patients known to be suf-
fering from lymphoedema within his community served
by a small local hospital (3 wards, daily medical out-pa-
tients). The principal researcher arranged to see these pa-
tients in the local hospital with a local nurse selected by
the doctor.
Patients were examined and the diagnosis of lymphoede-
ma was confirmed clinically and classified using the
scheme developed by Dreyer et al., in Brazil [12]. All pa-
tients were then interviewed as to their disease history and
current acute attack rates. They also were asked questions
on current knowledge, attitudes and practices (KAP) and
completed a Dermatology Life Quality Index (DLQI)
questionnaire either on their own or with the assistance of
the nurse if they were illiterate (2 patients).
The interventions subsequently undertaken in this com-
munity were:
1. Education and training of a local non-specialist nurse,
who was able to offer support and advice for patients
within her existing role in the hospital.
2. Individual patient education
3. Access to appropriate treatments.
After the patients had been clinically assessed and com-
pleted the DLQI questionnaire, they were individually ed-
ucated on LF and given appropriate advice on how to
manage their lymphoedema, and educated on the impor-
tance of hygiene, skin care and elevation, as well as simple
exercises to encourage lymph drainage. Treatment was
given from a formulary of antibiotics (Penicillin) if cur-
rent acute attack, antiseptics (potassium permanganate)
and topical creams (Bacitracin ointment and MiconazoleFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/1
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2%). Each patient was given a tube of topical antibacterial
and anti-fungal cream if clinically indicated and a patient
education leaflet [13].
It was agreed that the nurse could offer advice and support
to patients as and when they needed. Furthermore, the
nurse could also provide education for any further pa-
tients who presented with lymphoedema. This was within
her role as a nurse in Wismar hospital and did not require
any extra facilities or salary. The researcher spent approxi-
mately one hour with the nurse during which time the
current knowledge of LF pathophysiology, in particular
the difference between infection and disease, why many
patients with lymphoedema had negative blood films for
microfilaria and why DEC was not an effective treatment,
was explained. Morbidity reduction measures, which em-
phasized the importance of hygiene and skin care were
also explained and demonstrated. The nurse was given
further educational material and a supply of antiseptics,
antibiotics and topical antibiotic and anti-fungal creams.
Patients were advised to visit the nurse in the hospital out-
patients if they had acute attacks or needed help with any
issues. The nurse was invited to contact the researcher at
the PAHO office in Georgetown if she had any questions.
The researcher visited Wismar twice during the study peri-
od to supply topical antibiotic and anti-fungal creams as
required (from the Ministry of Health pharmacy bond).
Six months after the initial clinic study, the nurse attended
a LF workshop for health care workers in Linden. At this
point the nurse was provided with a patient video; 'Lym-
phatic Filariasis, Hope for a better life' (English version)
produced by the Centers for Disease Control and Preven-
tion (CDC), Atlanta. Over the course of the year, more pa-
tients attended the group, which developed by word of
mouth, as a result of the intervention.
The clinic was visited approximately one year later and the
patients were reassessed. The number of acute attacks dur-
ing the last year was recorded as reported by the patient
and the DLQI was repeated.
Results
14 patients were initially seen who had a clinical diagno-
sis of lymphoedema and who completed a DLQI. 11 pa-
tients were seen approximately one year later at the
follow-up visit and completed the DLQI. 3 of the initial
patients were not seen on this visit as they had moved
from the area, and were therefore excluded from the study
(Follow up = 79%). In addition, 5 patients were seen on
the follow-up visit that had begun to attend the clinic over
the past year.
Of the 11 initial patients included in the study, 9 were fe-
male and 2 were male. Their ages ranged from 21–65
(mean = 47) and they were all Afro-Guyanese (reflecting
the ethnic composition of the local population in Wis-
mar). The KAP study showed that before the intervention
patients had received haphazard care, including use of lo-
cal remedies and care from pharmacies, private doctors
and hospital clinics for acute attacks. There was very lim-
ited skin care and none of the patients were aware of the
importance of hygiene.
Initial DLQI ranged from 2–18 out of 30 points (mean
score = 10.9 points). Mean scores in skin patients in UK
for other conditions in a study of 200 patients were
around this range e.g. psoriasis: 8.9 points, atopic eczema:
12.5 points, acne: 4.3 points and controls: 0.5 points [5].
These scores confirmed the hypothesis that lymphoedema
has a significant impact on patient quality of life. The ini-
tial DLQI showed only a weak relationship to lymphoede-
ma severity as assessed by Dreyer stage of the worst
affected limb (0.33 Pearson's correlation coefficient). Ob-
viously this is only one assessment of disease severity and
factors such as frequency of acute attacks could also be
taken into consideration in future analysis.
The follow-up DLQI scores were the same or better for all
11 patients who had the two assessments. These DLQI
scores ranged between 0–11 points (mean score = 4.1
points) and the improvement varied between 0–15 points
(mean improvement 6.8 points). A paired t-test (to assess
the significance of the change in DLQI values for each per-
son) gave a value of 5.9 with 10 degrees of freedom (p = <
0.0001).
Patients also reported both a decrease in lymphoedema
severity and notably in acute attack rates. In the initial vis-
it, 10 out of the 11 patients had reported an acute attack
in the preceding 6 months; however, no reports of acute
attacks were made by any of the 11 patients in the 6
months preceding the follow up visit. It was not felt that
other clinical outcomes could be analysed accurately in
this small sample. The Dreyer stage did not change in any
of the patients and limb size had not been reliably meas-
ured on the first visit but even though results were not
measured objectively, patients did perceive subjective
clinical improvement.
Discussion
This study shows that in this community, with only a very
limited input of time and financial resources, a change/in-
troduction in treatment regime can have a beneficial im-
pact on patients with lymphoedema within a year. This
intervention used the existing services within the commu-
nity and gave them the necessary information enabling
them to put into place more informed treatment. The in-
tervention was easy to implement and required very lim-
ited follow up. This is valuable investment for a chronicFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/1
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condition, which is permanent once established. Howev-
er, follow up is essential to see if the effect continues over
time.
It was felt from this preliminary experience in Guyana that
the DLQI was an appropriate tool to assess how limb lym-
phoedema affected patient quality of life and in particular
to monitor an intervention that concentrated on skin care
treatment. A study involving larger numbers of patients
could assess in greater detail which features of life quality
relate specifically to lymphoedema patients, and how this
tool can be used along side other life quality measures.
There are a number of reasons why this intervention could
have improved quality of life (as measured by the DLQI).
In discussion with the patients and the nurse, likely con-
tributing factors raised were reduced clinical severity (in
particular a reduction in acute attacks) leading to an in-
creased ability to work and perform daily functions. Other
factors which were stated included the empowerment as-
sociated with an understanding of the condition and the
ability to manage it individually. Also cited as important
were the support from the clinic, the nomination of a clear
focal point (the designated nurse) in the hospital, the abil-
ity to meet with other patients and the networks that were
formed in the community.
Interestingly, the DLQI scores in the 5 new patients were
not as high as the initial group. This may reflect the fact
that the improvements in the quality of service, as well as
the establishment of the patient support group, benefited
new patients as well.
As this study was designed to provide the entire commu-
nity with access to treatment there were no controls and
therefore could be no estimation of the extent of a placebo
effect.
Further work on larger samples and more in-depth inves-
tigations of the degree, duration and cost of alternative ap-
proaches are needed to identify which of these factors had
the greatest effect.
The nurse was non-specialist but gained confidence from
her work in this area. She felt extremely positive about the
effect she was able to have on patients and the autonomy
she felt. She only contacted the PAHO office with requests
for further supplies of topical antibacterial and anti-fungal
creams and did not have any clinical questions that she
felt could not be answered by the educational material she
was provided with. She has been able to educate other
health workers, which raises the probability of sustaina-
bility of the intervention.
Conclusions
A minimal amount of intervention in this small sample
population has resulted in an improvement in patient
quality of life and ability to function within their commu-
nity. This study shows that low cost interventions, which
provide an initial centre for patient treatment and educa-
tion on disease management, can have a significant bene-
ficial impact on outcomes.
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